First half-year 2023 financial highlights (unaudited)
(€ millions, except basic & diluted income/loss (-) per share)
| Six months ended
30 June |
Change | ||
| 2023 | 2022 | ||
| Product net sales | 54.3 | 35.4 | +54% |
| Collaboration revenues | 274.5 | 238.6 | +15% |
| Total net revenues | 328.8 | 274.0 | +20% |
| Cost of sales | (7.8) | (5.5) | +41% |
| R&D expenditure | (211.9) | (249.5) | -15% |
| G&Aii and S&Miii expenses | (121.6) | (134.0) | -9% |
| Other operating income | 23.8 | 17.6 | +35% |
| Operating profit/loss (-) | 11.3 | (97.5) | |
| Fair value adjustments and net currency exchange differences | 0.2 | 71.9 | |
| Net other financial result | 30.4 | (4.3) | |
| Income taxes | (13.6) | (2.5) | |
| Net profit/loss (-) of the period | 28.3 | (32.3) | |
| Basic and diluted income/loss (-) per share (€) | 0.43 | (0.49) | |
| Current financial investments and cash and cash equivalents | 3,874.9 | 4,429.0 | |
